Plasticell and Veritas announce an exclusive distribution agreement in Japan

Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has today announced that it has engaged Veritas Corporation of Tokyo as the exclusive distributor for all of its services and products, including CombiCult®, in Japan. CombiCult® breaks the major bottleneck in stem cell research and development programmes – the discovery of optimised stem cell differentiation [...]

2021-06-01T11:48:03+01:00June 14th, 2012|Press Releases|

Plasticell announces grant of fundamental CombiCult® patents in USA and Japan

Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, today announced that patents for its combinatorial cell culture platform technology, CombiCult™, have been granted in the USA and Japan. Patents covering CombiCult™ have now been issued in Europe, USA, Japan, Australia and Singapore. CombiCult™ breaks the major bottleneck in stem cell research and development programmes [...]

2021-06-01T11:44:33+01:00February 13th, 2012|Press Releases|

Plasticell to collaborate with Pfizer, Cellzome and University of Sheffield in a £1.4 million Technology Strategy Board-funded stem cell project

Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced that the Technology Strategy Board has funded a research consortium comprising of Plasticell, Pfizer (Neusentis) and the University of Sheffield, led by Cellzome. The project will develop methods of characterizing stem cells through protein fingerprints predictive of changes in stem cell behaviour. The Technology [...]

2016-12-09T12:24:04+00:00January 10th, 2012|Press Releases|

Plasticell wins Technology Strategy Board funding for £1.5 million stem cell manufacturing project

Plasticell has announced that the Technology Strategy Board has made a further investment in the Company’s flagship technology, CombiCult™, the high throughput technology designed to solve the major bottleneck in stem cell research and development. The Technology Strategy Board will provide a grant of approximately £750k towards a £1.5 million project entitled ‘High Throughput Platform for the Discovery of GMP-Compatible [...]

2021-06-01T11:52:15+01:00December 6th, 2011|Press Releases|

Plasticell Delivers Differentiation Protocols to Stemnion, Inc.

Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced the successful completion of a collaboration with Stemnion, Inc. (Pittsburgh, PA), a US biotechnology company focused on the applications of stem cells derived from human placentas. Plasticell used its flagship technology CombiCult™ to discover multiple novel, serum-free protocols that direct the differentiation of Stemnion’s [...]

2016-12-09T12:23:12+00:00August 3rd, 2011|Press Releases|

Plasticell‘s CombiCult™ v2.0 platform wins international R&D 100 Award

Plasticell’s high throughput screen for stem cell differentiation joins list of the most significant technology products developed globally in the last 49 years Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has won the prestigious R&D 100 Award for its CombiCult™v2.0 system. The CombiCult™ platform is a high-throughput combinatorial screening technology that allows scientists [...]

2016-12-14T19:42:47+00:00June 23rd, 2011|Press Releases|

Plasticell Spins Out Regenerative Drug Discovery Venture

New demerged business called ‘Progenitor Labs’ Plasticell Ltd, the biotechnology company developing high throughput stem cell technologies, has announced today that following its recent £3.5m financing, it has undergone a strategic re-structuring to enable the Company to focus on its award winning CombiCult™ technology for stem cell differentiation. Consequently, Plasticell Ltd has demerged its regenerative drug discovery unit into a [...]

2016-12-09T12:04:04+00:00April 13th, 2011|Press Releases|

Plasticell completes £3.5 million financing round

Capital injection to expand business development and marketing initiatives Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced it has completed a two-part equity financing, raising a total of £3.5 million from new and existing investors. The first tranche of the financing, in which £1.5 million was drawn down in April 2009, was [...]

2016-12-09T12:03:18+00:00January 31st, 2011|Press Releases|

Plasticell signs technology agreement with Sigma-Aldrich

Collaboration to produce novel turnkey solution for stem cell research Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced the signing of a collaboration agreement with Sigma-Aldrich, a leading provider of technologies and reagents to the life science research market. In the collaboration, Sigma-Aldrich will use its CompoZr® Zinc Finger Nuclease Technology to [...]

2016-12-14T19:43:08+00:00November 29th, 2010|Press Releases|

Plasticell signs screening collaboration with UCB. First in kind deal to partner small molecule drugs for stem cell research

Plasticell, the biotechnology company specialising in the use of innovative high throughput technologies in stem cell research, has announced signing of a collaboration agreement with the biopharmaceutical company, UCB. Under the terms of the agreement, UCB will supply Plasticell with drug compound libraries with known biological targets. Plasticell will screen these using its award-winning CombiCult technology to discover new cell [...]

2017-01-17T07:21:30+00:00November 8th, 2010|Press Releases|